PEDRO LICHTINGER

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Lineage Cell Therapeutics, Inc.

Filing Date Source Excerpt
2012-04-30 Pedro Lichtinger, 57, joined the Board of Directors during August 2009. Mr. Lichtinger has been the President, Chief Executive Officer, and a director of Optimer Pharmaceuticals, Inc., since May 2010. ... The members of the Audit Committee are Arnold I. Burns, Abraham E. Cohen, and Pedro Lichtinger. ... The members of the Compensation Committee are Arnold I. Burns, Abraham E. Cohen, and Pedro Lichtinger. ... Pedro Lichtinger received total compensation of $124,969 in 2011.
2013-10-07 Mr. Lichtinger brings to our Board more than 20 years of experience in the pharmaceutical industry, where he played a key role in the development of international business for two leading pharmaceutical companies, Pfizer and Smith Kline Beecham. We believe that Mr. Lichtinger's experience in the international pharmaceutical industry will be of great value in our efforts to find and capitalize on opportunities in overseas markets.

Data sourced from SEC filings. Last updated: 2026-02-03